Physician

Luke C. Nicholas, MD

According to 2025 Medicare claims, Luke Nicholas, MD (NPI: 1467509620) practices micrographic dermatologic surgery in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is JACK A DEKKINGA MD PC (NPI: 1609896034; TIN: 382561981) and primary practice location at 49341-9244.

Nicholas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 248 traditional Medicare patients, billed 737 HCPCS/CPT codes, and received $181,275 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 196 prescription claims across 166 beneficiaries totaling $2,505 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 54 records totaling $1,127. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $122,351 to $181,275. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,072 and ending at $2,505. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$106K$212K2017 Medicare payment: $122,351 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $142,086 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $123,642 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $174,003 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $168,443 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $168,206 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $212,166 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $181,275 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017138434$122,351
2018151472$142,086
2019198580$123,642
2020203823$174,003
2021175615$168,443
2022195633$168,206
2023241789$212,166
2024248737$181,275

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2015 Drug cost: $1,072 (USD; Tot_Drug_Cst)2016 Drug cost: $2,165 (USD; Tot_Drug_Cst)2018 Drug cost: $657 (USD; Tot_Drug_Cst)2019 Drug cost: $8,891 (USD; Tot_Drug_Cst)2020 Drug cost: $55,910 (USD; Tot_Drug_Cst)2021 Drug cost: $2,762 (USD; Tot_Drug_Cst)2022 Drug cost: $2,931 (USD; Tot_Drug_Cst)2023 Drug cost: $6,322 (USD; Tot_Drug_Cst)2024 Drug cost: $2,505 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152123$1,072
20163345$2,165
2017N/RN/RN/R
20181115$657
2019123216$8,891
2020204409$55,910
2021159241$2,762
2022161222$2,931
2023246321$6,322
2024166196$2,505

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks172211$465
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks4869$307
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm4748$176
12032Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm3536$161
17000Destruction of precancer skin growth, 1 growth3739$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil25791$1,363
CephalexinCephalexin83581$391
MupirocinMupirocin24539$153
Doxycycline HyclateDoxycycline Hyclate18132$77
Clindamycin HclClindamycin Hcl1394$65

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.54$1,127Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Luke C. Nicholas, MD?

Tedicare shows public-source Medicare data for Luke C. Nicholas, MD (NPI 1467509620), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luke C. Nicholas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luke C. Nicholas, MD?

Luke C. Nicholas, MD is linked to JACK A DEKKINGA MD PC (billing NPI 1609896034) in the available physician profile data.

Does Luke C. Nicholas, MD have Open Payments data?

Luke C. Nicholas, MD has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.